COVID-19 and Heart Failure with Preserved and Reduced Ejection Fraction Clinical Outcomes among Hospitalized Patients

Adeel Nasrullah1, Karthik Gangu2, Harmon R Cannon3

  • 1Division of Pulmonology and Critical Care, Allegheny Health Network, Pittsburg, PA 15212, USA.

Viruses
|March 30, 2023
PubMed

Insights

Patients with acute heart failure exacerbation and COVID-19 face significantly higher in-hospital mortality and complications like mechanical ventilation and kidney failure compared to those without COVID-19. This highlights the severe impact of concurrent COVID-19 infection on heart failure outcomes.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Public Health

Background:

  • Heart failure exacerbations are a leading cause of morbidity and mortality.
  • Limited large-scale studies exist on outcomes of acute heart failure (CHF) with concurrent COVID-19.
  • Understanding these outcomes is critical for patient management and public health strategies.

Purpose of the Study:

  • To compare clinical outcomes in patients hospitalized with acute CHF with and without COVID-19 infection.
  • To identify risk factors and disparities associated with higher mortality in this patient population.
  • To inform clinical practice and resource allocation for managing CHF patients during the COVID-19 pandemic.

Main Methods:

  • Utilized the National Inpatient Sample (NIS) database for a large-scale retrospective study.
  • Identified 2,101,980 patients with acute CHF, including 75,215 with COVID-19.
  • Employed multivariate logistic regression, adjusting for demographics, comorbidities, and hospital characteristics.

Main Results:

  • Patients with acute CHF and COVID-19 had significantly higher in-hospital mortality (25.78% vs. 5.47%).
  • Higher rates of vasopressor use, mechanical ventilation, sudden cardiac arrest, and acute kidney injury were observed in the COVID-19 group.
  • Elderly patients, African Americans, and Hispanic individuals experienced higher mortality rates.

Conclusions:

  • Concurrent COVID-19 infection dramatically increases in-hospital mortality for acute CHF exacerbations.
  • COVID-19 exacerbates end-organ dysfunction, including kidney failure and cardiac arrest, in heart failure patients.
  • Disparities in mortality exist among different demographic groups, warranting targeted interventions.

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.7K
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
23
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
29
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
28
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
18
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
19